investors.impaxlabs.com investors.impaxlabs.com

investors.impaxlabs.com

Impax Laboratories, Inc. - Investor Relations

Skip to main content. Quarterly and Other Reports. Executive Officers and Directors. Pricing delayed 20 minutes. Review the latest results, trading conditions and financial reports. View upcoming events and latest presentations. March 1, 2017. Opens in new window). February 28, 2017. Opens in new window). Get answers to important investor relations questions. Get answers to your investor relations questions. Get answers to important investor relation questions. Impax Laboratories, Inc. Powered By Q4 Inc.

http://investors.impaxlabs.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.IMPAXLABS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 8 reviews
5 star
5
4 star
1
3 star
1
2 star
0
1 star
1

Hey there! Start your review of investors.impaxlabs.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.6 seconds

FAVICON PREVIEW

  • investors.impaxlabs.com

    16x16

  • investors.impaxlabs.com

    32x32

CONTACTS AT INVESTORS.IMPAXLABS.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Impax Laboratories, Inc. - Investor Relations | investors.impaxlabs.com Reviews
<META>
DESCRIPTION
Skip to main content. Quarterly and Other Reports. Executive Officers and Directors. Pricing delayed 20 minutes. Review the latest results, trading conditions and financial reports. View upcoming events and latest presentations. March 1, 2017. Opens in new window). February 28, 2017. Opens in new window). Get answers to important investor relations questions. Get answers to your investor relations questions. Get answers to important investor relation questions. Impax Laboratories, Inc. Powered By Q4 Inc.
<META>
KEYWORDS
1 about impax
2 company profile
3 history
4 vision and values
5 executive team
6 board of directors
7 business development
8 locations
9 generic products
10 product listings
CONTENT
Page content here
KEYWORDS ON
PAGE
about impax,company profile,history,vision and values,executive team,board of directors,business development,locations,generic products,product listings,product packaging information,generic trade relations,generic product contacts,specialty products,news
SERVER
nginx/1.12.1
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Impax Laboratories, Inc. - Investor Relations | investors.impaxlabs.com Reviews

https://investors.impaxlabs.com

Skip to main content. Quarterly and Other Reports. Executive Officers and Directors. Pricing delayed 20 minutes. Review the latest results, trading conditions and financial reports. View upcoming events and latest presentations. March 1, 2017. Opens in new window). February 28, 2017. Opens in new window). Get answers to important investor relations questions. Get answers to your investor relations questions. Get answers to important investor relation questions. Impax Laboratories, Inc. Powered By Q4 Inc.

INTERNAL PAGES

investors.impaxlabs.com investors.impaxlabs.com
1

Impax Laboratories Inc. - Investor Relations - E-mail Alerts

https://investors.impaxlabs.com/English/Investor-Relations/Email-Alerts/default.aspx

You may automatically receive Impax Laboratories financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and check the boxes corresponding to the updates you are interested in, then click Submit. To change your e-mail options at any time, re-enter your e-mail address, adjust your form entries and click Submit. End of Day Stock Quote. Enter the code shown above.

2

Impax Laboratories Inc. - Goldman Sachs 36th Annual Global Healthcare Conference

https://investors.impaxlabs.com/Investor-Relations/Events-and-Presentations/Event-Details/2015/Goldman-Sachs-36th-Annual-Global-Healthcare-Conference/default.aspx

Goldman Sachs 36th Annual Global Healthcare Conference. June 11, 2015. Time: 09:20 AM PST. Click here for webcast. View the Press Release. View the Related Document. First Name is required. Enter the code shown above. Powered By Q4 Web Systems.

3

Impax Laboratories Inc. - Media Center - Press Releases

https://investors.impaxlabs.com/Media-Center/Press-Releases/default.aspx

August 26, 2016. Impax Laboratories, Inc. Issues Voluntary, Nationwide Recall for One Lot of Lamotrigine Orally Disintegrating Tablet 200 mg Due to the Potential for 100 mg Blister Cards being Packaged in 200 mg Containers. August 22, 2016. Richard A. Bierly Appointed to Impax Laboratories Board of Directors. August 9, 2016. Impax Reports Second Quarter 2016 Financial Results. July 21, 2016. Impax Names Douglas S. Boothe President of Generics Division. July 7, 2016. June 21, 2016. June 2, 2016. Impax Rec...

4

Impax Laboratories Inc. - Impax to Report Second Quarter 2015 Results on August 10, 2015

https://investors.impaxlabs.com/Media-Center/Press-Releases/Press-Release-Details/2015/Impax-to-Report-Second-Quarter-2015-Results-on-August-10-2015/default.aspx

Impax to Report Second Quarter 2015 Results on August 10, 2015. Download this Press Release. July 6, 2015. Impax Laboratories, Inc. Announced today that the Company will release its second quarter 2015 financial results on. Monday, August 10, 2015. Prior to the open of the U.S. financial markets. The Company will host a conference call and live webcast with the investment community at. 8:30 am, Eastern Time. August 10, 2015. Impax Laboratories, Inc. Investor Relations and Corporate Communications.

5

Impax Laboratories Inc. - Impax Completes Acquisition Of Tower Holdings, Inc. And Lineage Therapeutics Inc.

https://investors.impaxlabs.com/Media-Center/Press-Releases/Press-Release-Details/2015/Impax-Completes-Acquisition-Of-Tower-Holdings-Inc-And-Lineage-Therapeutics-Inc/default.aspx

Impax Completes Acquisition Of Tower Holdings, Inc. And Lineage Therapeutics Inc. Download this Press Release. Provides 2015 Financial Guidance -. Announces New Division Structure and Corporate Logo -. Impax to Host Conference Call Today at 8:30 AM ET -. March 10, 2015. Impax Laboratories, Inc. NASDAQ: IPXL) today announced that it has completed its acquisition of. Tower Holdings, Inc. Together, the "Companies"). In connection with the closing of the acquisition,. President and chief executive officer of.

UPGRADE TO PREMIUM TO VIEW 6 MORE

TOTAL PAGES IN THIS WEBSITE

11

LINKS TO THIS WEBSITE

impaxlabs.com impaxlabs.com

Our Divisions | Impax Laboratories, Inc.

http://www.impaxlabs.com/our_divisions

Our Two Corporate Divisions. We have two platforms that offer the right balance for future growth. Our vision is to target key areas of growth that reflect both our internal strengths, and a strong market, treatment or product need. At Impax Laboratories we are following a growth-oriented strategy to become a leader in the development, manufacturing and marketing of specialty prescription pharmaceutical products. Purchase Order Terms and Conditions.

impaxlabs.com impaxlabs.com

Sitemap | Impax Laboratories, Inc.

http://www.impaxlabs.com/sitemap

Primary Nav: Impax Labs. Utility Nav: Impax Labs. Purchase Order Terms and Conditions.

impaxlabs.com impaxlabs.com

Media Center | Impax Laboratories, Inc.

http://www.impaxlabs.com/media_center

Impax at a Glance. Welcome to our Media Center. Our Mission - To be a leader in the development, manufacturing and marketing of generic and branded pharmaceuticals utilizing our formulation expertise and unique drug delivery technologies, focusing on opportunities that increase shareholder value and provide long-term profitable growth. Founded – Impax Laboratories was formed in December 1999 through the merger of publicly traded Global Pharmaceuticals and privately held Impax Pharmaceuticals.

impaxpharma.com impaxpharma.com

Product Pipeline | Impax Pharmaceuticals

http://www.impaxpharma.com/rd_focus/product_pipeline

Our pipeline is focused on targeting significant unmet needs, with a primary focus on developing treatments for movement disorders in the field of neurolology. In January 2014, Impax and DURECT signed an agreement granting Impax the exclusive worldwide rights to develop and commercialize IPX239, an investigational transdermal bupivacaine patch for the treatment of pain associated with post-herpetic neuralgia (PHN).

impaxpharma.com impaxpharma.com

Careers | Impax Pharmaceuticals

http://www.impaxpharma.com/careers

Impax Pharmaceuticals is the brand division of Impax Laboratories, Inc. Our mission is to create and deliver world-leading pharmaceutical products requiring a team with exceptional talent, skills and dedication. If you want to share in that mission, consider joining our team. To learn more about opportunities across our company, please visit the Impax Labs Careers section. Impax Laboratories Careers Section.

impaxlabs.com impaxlabs.com

Our Experience | Impax Laboratories, Inc.

http://www.impaxlabs.com/our_experience

Experience Is Our Strength. At Impax Laboratories we have created a strong platform for growth built on a broad base of drug delivery expertise, formulation technology and experience in product development. Impax Generics Division has a wealth of experience and a track record of product approvals. Investing in our people is a key ingredient to our success and a benefit in building a strong organization. Within our Generics Division:. 21 products pending at the FDA. 21 products under development. RYTARY (...

impaxlabs.com impaxlabs.com

Specialty Pharma | Impax Laboratories, Inc.

http://www.impaxlabs.com/our_divisions/specialty_pharma

Our Specialty Pharma Division is a neurology-focused, specialty pharmaceutical company, dedicated to developing products for unmet needs in the treatment of Central Nervous System (CNS) disorders. Experience in Neurology Research. In February 2012, we licensed from AstraZeneca the exclusive U.S. commercial rights to Zomig (zolmitriptan) tablet, orally disintegrating tablet, and nasal spray formulations pursuant to the terms of the AZ Agreement and began sales of the Zomig products under our label...Zomig...

impaxlabs.com impaxlabs.com

Products and Pipeline | Impax Laboratories, Inc.

http://www.impaxlabs.com/our_experience/products_and_pipeline

An Expanding Product Portfolio. Impax’s ongoing strategy to invest in R&D and to develop high-value opportunities should continue to provide the potential for growth in the future. Within our Specialty Pharma Division, we market:. Learn more about our Generics Division. Learn more about our Specialty Pharma Division. We currently have 21 pending Abbreviated New Drug Applications (ANDA) at the FDA. We are also working on an additional 21 products under development with many having the potential to be ...

impaxlabs.com impaxlabs.com

Generics Division | Impax Laboratories, Inc.

http://www.impaxlabs.com/our_divisions/impax_generics

Impax has developed a portfolio of generic pharmaceuticals through the internal filing of Abbreviated New Drug Applications (ANDAs) and through partnerships on alternative dosage form products. Our generic product development strategy is based on a combination of speed to filing and a legal strategy primarily predicated upon non-infringement of established brand name pharmaceuticals. We are focused on targeting high-value solid oral and alternative dosage form ANDAs that are difficult to develop ...We ha...

impaxlabs.com impaxlabs.com

Careers | Impax Laboratories, Inc.

http://www.impaxlabs.com/careers

We Make a Difference Join Us. At Impax we are focused on continuing our history as a successful and profitable company, on meeting the challenge of an ever-changing healthcare environment, and on ensuring a productive and enjoyable place to work. Join the ever-growing number of employees who are helping to improve healthcare by developing, manufacturing and marketing prescription and over-the-counter pharmaceutical products using innovative formulations and unique drug delivery technologies. Impax is jus...

UPGRADE TO PREMIUM TO VIEW 32 MORE

TOTAL LINKS TO THIS WEBSITE

42

OTHER SITES

investors.idhcorp.com investors.idhcorp.com

About Us – IDH

Skip to main content. IDH (Integrated Diagnostics Holdings). To provide the highest quality and most efficient medical laboratory services at reasonable prices. To maintain and even enhance our business credibility, and the trust we have gained through our industrious endeavor to become the best and most reliable medical laboratory services in Egypt and the Middle East. Integrated Diagnostics Holdings plc. The Company's registered and head office is at 12 Castle Street, St Helier, Jersey JE2 3RT.

investors.ididata.com investors.ididata.com

Interactive Data | IDI

160; 0.10. Data as of Aug 18, 2015 2:05 pm ET. IDI, Inc. is an information solutions provider focused on the multi-billion dollar data-fusion market. IDI delivers otherwise unattainable insight into the ever-expanding universe of consumer- and business-centric data. Aug 14, 2015. IDI, Inc. Reports Second Quarter 2015 Results. Jul 24, 2015. IDI, Inc. Announces $10 Million Registered Direct Offering. Jul 08, 2015. IDI, Inc. Launches idiBASIC Information Solution Offering. Jul 02, 2015. Aug 17, 2015.

investors.idoxgroup.com investors.idoxgroup.com

Idox plc - Investors home

Jump to main navigation. Engineering Information Management Software. Board committees and Director responsibilities. Idox Companies Statutory Information. Idox group is a supplier of software solutions and services to the UK public sector and increasingly to the wider corporate sector. LSE: Idox plc profile. IDOX Annual Report 2017. Published 27 March 2018. IDOX PLC - Notice of Annual General Meeting. Published 27 March 2018. Idox plc - Proxy AGM2018. Published 27 March 2018. Holding(s) in Company,.

investors.illegalburgerco.com investors.illegalburgerco.com

Illegal Burger Investors | Just another WordPress site

Investors Email Sign up Here. Want to learn how you can invest directly with Illegal Burger? Looking to become a franchisee? Enter your Email Below and one of our Investor Relations Associates will be in touch. Investor Information and Contact. Our future growth plan incorporates our own corporate location growth as well as Franchise growth; therefore boosting the profit margin and introducing a new commercial base of business that would be untapped up to this point for us.

investors.impacthomes.com.au investors.impacthomes.com.au

Investor Login - Impact Homes

IHub gives you 24/7 direct online access to financial reports and business updates for the Impact Group AUS. V20161.1.1 [2016.1.1.1].

investors.impaxlabs.com investors.impaxlabs.com

Impax Laboratories, Inc. - Investor Relations

Skip to main content. Quarterly and Other Reports. Executive Officers and Directors. Pricing delayed 20 minutes. Review the latest results, trading conditions and financial reports. View upcoming events and latest presentations. March 1, 2017. Opens in new window). February 28, 2017. Opens in new window). Get answers to important investor relations questions. Get answers to your investor relations questions. Get answers to important investor relation questions. Impax Laboratories, Inc. Powered By Q4 Inc.

investors.impellam.com investors.impellam.com

Impellam | Overview

Our vision is to be the world`s most trusted staffing company - trusted by our people, our customers and our investors in equal measure. View our board members. Delayed by at least 15 minutes. View detailed share price. Oversees the Group’s internal risk and controls strategy, including whistleblowing arrangements. Reviews the Annual Report and interim financial statements prior to submission to the full Board. Reviews reports from external auditor. Reviews the Group’s risk register. Lord Ashcroft KCMG PC.

investors.imperva.com investors.imperva.com

Imperva | Investors | Corporate Governance

Nominating and Corporate Governance Committee. Whistleblower and Complaint Policy. Code of Business Conduct and Ethics. Committee Structure and Composition. Below is a summary of our committee structure and membership information. Nominating and Corporate Governance Committee. Stockholder correspondence should be mailed to:. College Station, TX 77842-3170. Overnight correspondence should be sent to:. 211 Quality Circle, Suite 210. College Station, TX 77845. Http:/ www.computershare.com/investor.

investors.imuc.com investors.imuc.com

Investor Relations - ImmunoCellular

April 14, 2015 - CEO Andrew Gengos interview with The Wall Street Analyzer. August 13, 2015. ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma. August 6, 2015. ImmunoCellular Therapeutics Announces Second Quarter 2015 Financial Results. View all press releases ». August 6, 2015 at 2:00 PM PT. ImmunoCellular Therapeutics Second Quarter 2015 Financial Results. July 8, 2015 at 2:30 PM ET.

investors.inasentence.org investors.inasentence.org

investors in a sentence | simple examples

In A Sentence .org. The best little site that helps you understand word usage with examples. Investors in a sentence. In its Future,. Use abscising in a sentence. Use bearer in a sentence. Use dedicate in a sentence. Use diarys in a sentence. Use dusters in a sentence. Use equivalences in a sentence. Use everybodys in a sentence. Use horsemint in a sentence. Use metallurgist in a sentence. Use tribology in a sentence. Popular Words This Week. In its Future, Investors. They are their investors.

investors.inb.com investors.inb.com

IRWeblink

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail [email protected]. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.